This article was originally published with the title "Perspectives: Antidepressants: Good Drugs or Good Marketing"
- Andrew Mosholder’s originally blocked report urging new curbs on SSRIs may be viewed at www.ahrp.org/risks/SSRImosholder/
- Suppression of Mosholder’s findings and testimony is documented by Anna Wilde Mathews’s article “In Debate over Antidepressants, FDA Weighed Risk of False Alarm Doubting Data on Suicide and Kids” in Wall Street Journal; May 25, 2004. Viewable at www.ahrp.org/infomail/04/05/25.html
- Drug Company Experts Advised Staff to Withhold Data about SSRI Use in Children. Wayne Kondro in Canadian Medical Association Journal, Vol. 170; No. 5; March 2, 2004. Available online at www.cmaj.ca/cgi/content/full/170/5/783